Viewing Study NCT05732103


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-01-25 @ 8:33 AM
Study NCT ID: NCT05732103
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2023-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Sponsor: Chordia Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Syndromes View
Keywords: